Ganga Pharmaceuticals Ltd
BSE: 539680
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q4 FY25 | Q2 FY25 | Q4 FY24 | Q2 FY24 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 1.37+3.1% | 1.33+1.1% | 1.31-7.4% | 1.42+7.4% | 1.32 |
| Other Income | 0.15+3.5% | 0.14-51.2% | 0.29+94.0% | 0.15+69.7% | 0.09 |
| Total Income | 1.51+3.1% | 1.47-8.4% | 1.60+2.4% | 1.57+11.3% | 1.41 |
| EXPENSES | |||||
| Expenditure | 1.48+2.7% | 1.44-6.2% | 1.54+0.9% | 1.52+9.6% | 1.39 |
| Tax | 0.01-67.9% | 0.03-34.9% | 0.04+207.1% | 0.01+366.7% | 0.00 |
| PROFIT | |||||
| PBT | 0.03+21.4% | 0.03-58.2% | 0.07+48.9% | 0.04+136.8% | 0.02 |
| Net Profit | 0.03-54.5% | 0.06+129.2% | 0.02-20.0% | 0.03+87.5% | 0.02 |
| KEY METRICS | |||||
| OPM % | -15.00%+2.12pp | -17.12%+8.81pp | -25.93%-10.53pp | -15.40%-0.77pp | -14.63% |
| NPM % | 1.65%-2.09pp | 3.74%+2.24pp | 1.50%-0.41pp | 1.91%+0.77pp | 1.14% |
| EPS | 0.04-63.6% | 0.11+120.0% | 0.05-28.6% | 0.07+75.0% | 0.04 |
Corporate Events
Board MeetingGANGAPHARM
202416May
Board Meeting
Consider and approve the Audited Financial Results
BSE Filing ↗